Clinical Trial Update: Prednisolone in Early Diffuse Systemic Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating prednisolone in early diffuse systemic sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: Prof. Ariane herrick | Conditions: Systemic Sclerosis | Phase 2 | Status: COMPLETED